Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Carpio, A; Bonilla, LL; Dell'Acqua, G
   Motion of wave fronts in semiconductor superlattices - art. no. 036204
   PHYSICAL REVIEW E
   
   A. Carpio et al., "Motion of wave fronts in semiconductor superlattices - art. no. 036204", PHYS REV E, 6403(3), 2001, pp. 6204
2. Gov, Y; Bitler, A; Dell'Acqua, G; Torres, JV; Balaban, N
   RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis
   PEPTIDES
   
   Y. Gov et al., "RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis", PEPTIDES, 22(10), 2001, pp. 1609-1620
3. Ehsan, A; Mann, MJ; Dell'Acqua, G; Dzau, VJ
   Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide genetherapy
   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
   
   A. Ehsan et al., "Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide genetherapy", J THOR SURG, 121(4), 2001, pp. 714-722
4. Dell'Acqua, G; Polishchuck, R; Fallon, JT; Gordon, JW
   Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain human multiple drug resistance 1 fusion gene
   HUMAN GENE THERAPY
   
   G. Dell'Acqua et al., "Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain human multiple drug resistance 1 fusion gene", HUM GENE TH, 10(8), 1999, pp. 1269-1279
5. Mann, MJ; Whittemore, AD; Donaldson, MC; Belkin, M; Conte, MS; Polak, JF; Orav, EJ; Ehsan, A; Dell'Acqua, G; Dzau, VJ
   Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial
   LANCET
   
   M.J. Mann et al., "Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial", LANCET, 354(9189), 1999, pp. 1493-1498